Trial Details
COMPLETEDBasic Information
| Clinical ID | c1790 |
|---|---|
| Identifier | NCT02914561 |
| Trial Title | Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Filgotinib|OTHER: Placebo |
Participant Information
| Sponsor | Galapagos NV |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2016-10-31 |
|---|---|
| Primary Completion Date | 2022-11-11 |
| Completion Date | 2022-11-11 |